Mga Batayang Estadistika
| CIK | 1597892 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to JRSIS Health Care Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| March 3, 2025 |
OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0167 Expires: August 31, 2027 Estimated average burden hours per response 1.50 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| December 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-56013 JRSIS H |
|
| November 14, 2024 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: April 30, 2025 Washington, D. |
|
| September 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-56013 JRSIS HEALTH |
|
| August 15, 2024 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: February 28, 2022 Washington, D. |
|
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-56013 JRSIS HEALT |
|
| May 16, 2024 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: April 30, 2025 Washington, D. |
|
| April 26, 2024 |
EXHIBIT 21 Subsidiaries of JRSIS Health Care Corporation, a Florida corporation JRSIS Health Care Limited, a limited company organized in the British Virgin Islands Runteng Medical Group Company Limited, a limited company organized in Hong Kong Laidian Technology (Zhongshan) Co., Ltd., a limited company organized in the People’s Republic of China |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-56013 JRSIS HEALTH CARE CORPORAT |
|
| April 11, 2024 |
Exhibit 16 April 11, 2024 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 U.S.A. Ladies and Gentlemen: We have read Item 4.01 of this Form 8-K of JRSIS Health Care Corporation (the “Company”) dated and filed with the Securities and Exchange Commission on April 11, 2024, and are in agreement with the statements concerning our firm contained in the first, second, th |
|
| April 11, 2024 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2023 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission File Number) |
|
| March 29, 2024 |
OMB APPROVAL UNITED STATES OMB Number: 3235-0058 SECURITIES AND EXCHANGE COMMISSION Expires: April 30, 2025 Washington, D. |
|
| December 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2023 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission File Number) |
|
| December 1, 2023 |
Exhibit 10.b 独家业务合作协议 Exclusive Business Cooperation Agreement 本独家业务合作协议(“本协议”)由以下双方于 2023年11月30日在中华人民共和国 (“中国”) 中山市签署。 This Exclusive Business Cooperation Agreement (this “Agreement”) is made and entered into by and between the following parties on November 30, 2023 in Zhongshan , the People’s Republic of China (“China” or the “PRC”). 甲方：莱电科技（中山）有限公司 住所：中山市五桂山长命水长逸路19号德润园A座3楼 Party A: Laidian Tec |
|
| December 1, 2023 |
Exhibit 10.c 股权质押协议 Equity Interest Pledge Agreement 本股权质押协议（下称“本协议”)由下列各方于 2023年11月30日在 中华人民共和国（下称＂中国”)中山市签订。 This Equity Interest Pledge Agreement (this “Agreement”) has been executed by and among the following parties on November 30, 2023 in Zhongshan City, the People’s Republic of China (“China” or the “ PRC”): 甲方（下称“质权方”) : 莱电科技（中山）有限公司 住所：中山市五桂山长命水长逸路19号德润园A座3楼 Party A (hereinafter “ Pledgee |
|
| December 1, 2023 |
Exhibit 10.e 授权委托书 Power of Attorney 本公司广州巨米智能设备有限公司，统一社会信用代码：914401115876445175, 在本授权委托书签署之日拥有永州巨米智能科技有限公司（“内资公 司”) 100%的股权。就本公司在内资公司现时和将来持有的股权(“本公司股权”)’本公司特此不可撤销地授权莱电科技（中山）有限公司 (“独资公司”)在本授权委托书的有效期内行使如下权利： I, Guangzhou Jumi Intelligent Equipment Co., LTD.，unified Social credit code: 914401115876445175, and a holder of 100% of the entire registered capital in Yongzhou Jumi Intelligent Technology C |
|
| December 1, 2023 |
Exhibit 10.d 独家购买权协议 Exclusive Option Agreement 本独家购买权协议（下称“本协议”)由以下各方于 2023 年 11月30日在中华人民共和国（下称“中国”)中山市签订： This Exclusive Option Agreement (this “Agreement”) is executed by and among the following Parties as of the on November 30, 2023 in Zhongshan, the People’s Republic of China (“China” or the “PRC”): 甲方：莱电科技（中山）有限公司 住所：中山市五桂山长命水长逸路19号德润园A座3楼 Party A: Laidian Technology (Zhongshan) Co., Ltd Add |
|
| December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2023 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission File Number) |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS |
|
| November 14, 2023 |
OMB APPROVAL UNITED STATES OMB Number: 3235-0058 SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2022 Washington, D. |
|
| October 18, 2023 |
Exhibit 10.a AGREEMENT TO CONTRACT DATE: October 18, 2023 (the “Effective Date”) PARTIES: “JRSIS” JRSIS Health Care Corporation, a Florida corporation 3/F Building A, De Run Yuan, No. 19 Chang Yi Road, Chang Ming Shui, Wu Gui Shan, Zhong Shan City 528458 P.R. China “Laidian” Laidian Technology (Zhongshan) Co., Ltd. 3/F Building A, De Run Yuan, No. 19 Chang Yi Road, Chang Ming Shui, Wu Gui Shan, Zh |
|
| October 18, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2023 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Emplo |
|
| August 31, 2023 |
JRSIS HEALTH CARE CORP. 3/F Building A, Derunyuan No. 19 Changyi Road, Changmingshui Wuguishan, Zhongshan City 528458 People’s Republic of China August 31, 2023 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Jessica Ansart Abby Adams Christopher Dunham Jeanne Baker Terence O’Brien Re: JRSIS Health Care Corp. Form |
|
| August 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-K/A (Amendment No. 2) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000 |
|
| August 31, 2023 |
Exhibit 21 Subsidiaries of JRSIS Health Care Corporation, a Florida corporation JRSIS Health Care Limited, a limited company organized in the British Virgin Islands Runteng Medical Group Company Limited, a limited company organized in Hong Kong Laidian Technology (Zhongshan) Co., Ltd., a limited company organized in the People’s Republic of China |
|
| August 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEAL |
|
| August 14, 2023 |
OMB APPROVAL UNITED STATES OMB Number: 3235-0058 SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2022 Washington, D. |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2023 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission File Number) (I. |
|
| August 7, 2023 |
Letter from Centurion ZD CPA & Co. Exhibit 16 August 7, 2023 U.S. Securities & Exchange Commission 100 F Street, NE Washington, DC 20549 U.S.A. Ladies and Gentlemen: We have read the statements concerning our firm contained in Item 4.01 of this Form 8-K of JRSIS Health Care Corporation dated and filed with the Securities and Exchange Commission on August 7, 2023 and are in agreement with the statements concerning our firm contained |
|
| July 26, 2023 |
Exhibit 21 Subsidiaries of JRSIS Health Care Corporation, a Florida corporation JRSIS Health Care Limited, a limited company organized in the British Virgin Islands Runteng Medical Group Company Limited, a limited company organized in Hong Kong Laidian Technology (Zhongshan) Co., Ltd., a limited company organized in the People’s Republic of China |
|
| July 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001 |
|
| July 26, 2023 |
JRSIS HEALTH CARE CORP. 3/F Building A, Derunyuan No. 19 Changyi Road, Changmingshui Wuguishan, Zhongshan City 528458 People’s Republic of China July 26, 2023 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Jessica Ansart Abby Adams Christopher Dunham Jeanne Baker Terence O’Brien Re: JRSIS Health Care Corp. Form 10 |
|
| July 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SPDSCL-HFCAA-GOV JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in charter) Florida 001-36758 46-4562047 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 3/F (Building A), De Run Yuan, No. 19 Chang Yi Road, Chang Ming Shui, Wu Gui Shan Zhongsha |
|
| June 29, 2023 |
Articles of Amendment of Articles of Incorporation filed on June 26, 2023. Exhibit 3.a Articles of Amendment to Articles of Incorporation of JRSIS HEALTH CARE CORPORATION (Name of Corporation as currently filed with the Florida Dept. of State) P13000094777 (Document umber of Corporation (if known) Pursuant to the provisions of section 607.1006, Florida Statutes, this Florida Profit Corporation adopts the following amendment(s) to its Articles of lncorporation: A. If amen |
|
| June 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission File Number) (I. |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEA |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement JRSIS HEALTH CARE CORPORATION (Name of Registran |
|
| May 15, 2023 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Washington, D. |
|
| May 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement JRSIS HEALTH CARE CORPORATION (Name of Registran |
|
| April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-56013 JRSIS HEALTH |
|
| April 17, 2023 |
Exhibit 21 SUBSIDIARIES OF THE COMPANY SUBSIDIARIES JRSIS Health Care Limited, organized in the British Virgin Islands Runteng Medical Group Company Limited, organized in Hong Kong Laidian Technology (Zhongshan) Co. Ltd., organized in the People’s Republic of China |
|
| March 31, 2023 |
NT 10-K 1 ea176103-nt10kjrsisheal.htm NOTIFICATION OF LATE FILING UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: April 30, 2025 Washington, D.C. 20549 Estimated average burden Hours per response 2.5 FORM 12b-25 SEC FILE NUMBER 0-56013 NOTIFICATION OF LATE FILING CUSIP NUMBER 466280104 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS |
|
| September 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEAL |
|
| August 15, 2022 |
NT 10-Q 1 ea164319-nt10qjrsishealth.htm NOTIFICATION OF LATE FILING UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Washington, D.C. 20549 Expires: February 28, 2022 Estimated average burden Hours per response 2.5 FORM 12b-25 SEC FILE NUMBER 0-56013 NOTIFICATION OF LATE FILING CUSIP NUMBER 466280104 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ |
|
| June 28, 2022 |
JRSS / JRSIS Health Care Corp / Zhong Zhuowei - SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ?240. |
|
| June 9, 2022 |
Exhibit 10.a |
|
| June 9, 2022 |
Exhibit 10.b |
|
| June 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2022 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| May 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEA |
|
| May 16, 2022 |
NT 10-Q 1 ea160009-nt10qjrsisheal.htm NOTIFICATION OF LATE FILING UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: February 28, 2022 Washington, D.C. 20549 Estimated average burden Hours per response 2.5 FORM 12b-25 SEC FILE NUMBER 0-56013 NOTIFICATION OF LATE FILING CUSIP NUMBER 466280104 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Fo |
|
| April 15, 2022 |
EXHIBIT 4.6 DESCRIPTION OF COMMON STOCK Our only class of security registered pursuant to Section 12(g) of the Securities Exchange Act is our common stock, $0.001 par value per share. 100,000,000 shares of common stock are authorized. The holders of the Common Stock have equal ratable rights to dividends from funds legally available if and when declared by the Registrant?s board of directors (the |
|
| April 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-56013 JRSIS HEALTH CA |
|
| April 15, 2022 |
EXHIBIT 21 SUBSIDIARIES OF THE COMPANY SUBSIDIARIES JRSIS Health Care Limited, organized in the British Virgin Islands Runteng Medical Group Company Limited, organized in Hong Kong Harbin Jiarun Hospital Co. |
|
| March 31, 2022 |
NT 10-K 1 ea157677-nt10kjrsisheal.htm NOTIFICATION OF LATE FILING UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number:3235-0058 Washington, D.C. 20549 Expires: February 28, 2022 Estimated average burden Hours per response 2.5 FORM 12b-25 SEC FILE NUMBER 0-56013 NOTIFICATION OF LATE FILING CUSIP NUMBER 466280104 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ For |
|
| November 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 23, 2021 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission File Number) |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS |
|
| August 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEAL |
|
| August 16, 2021 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Washington, D. |
|
| July 6, 2021 |
As filed with the Securities and Exchange Commission on July 6, 2021 As filed with the Securities and Exchange Commission on July 6, 2021 Registration No. |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEA |
|
| April 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2021 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| April 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2021 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| April 15, 2021 |
EX-21 2 f10k2020ex21jrsishealth.htm SUBSIDIARIES OF THE COMPANY EXHIBIT 21 SUBSIDIARIES OF THE COMPANY SUBSIDIARIES JRSIS Health Care Limited, organized in the British Virgin Islands Runteng Medical Group Company Limited, organized in Hong Kong Harbin Jiarun Hospital Co., Ltd., organized in the People’s Republic of China Harbin Jiarun Hospital Co., Ltd. (Nanjing Road), organized in the People’s Re |
|
| April 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-56013 JRSIS HEALTH CA |
|
| March 31, 2021 |
NT 10-K 1 ea138709-nt10kjrsishealth.htm CURRENT REPORT UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: February 28, 2022 Washington, D.C. 20549 Estimated average burden Hours per response 2.5 FORM 12b-25 SEC FILE NUMBER 0-56013 NOTIFICATION OF LATE FILING CUSIP NUMBER 466280104 (Check One): x Form 10-K o Form 20-F o Form 11-K ¨ Form 10-Q o Form 10-D o F |
|
| March 22, 2021 |
Exhibit 99 The region?s first ?intelligent temperature detection robot? was put into use, JRSS launched a scientific and technological war against COVID-19 JRSS (Harbin Jiarun hospital) took the lead in introducing four of the most advanced ?intelligent temperature detection robots? to offer assistance in scientific epidemic containment. |
|
| March 22, 2021 |
Financial Statements and Exhibits, Other Events 8-K 1 ea138136-8kjrsishealth.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2021 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State o |
|
| March 22, 2021 |
EX-99 2 ea138136ex99jrsishealth.htm PRESS RELEASE DATED MARCH 21, 2021 REGARDING THE HARBIN JIARUN HOSPITAL DEPARTMENT OF PSYCHIATRY Exhibit 99 As the region’s first practice, the Department of Psychiatry of JRSS has been opened for consultation In order to meet the mental health needs of common people, the Department of Psychiatry of JRSS (Harbin Jiarun hospital) was officially opened for consult |
|
| March 22, 2021 |
Financial Statements and Exhibits, Other Events 8-K 1 ea138135-8kjrsishealth.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2021 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State o |
|
| December 10, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2020 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Emplo |
|
| November 13, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS |
|
| October 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2020 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Emplo |
|
| October 22, 2020 |
- DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| October 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| August 21, 2020 |
- POST-EFFECTIVE AMENDMENT NO. 2 TO REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on August 21, 2020 Registration No. |
|
| August 14, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEAL |
|
| August 5, 2020 |
8-K 1 ea125036-8kjrsis.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2020 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Othe |
|
| June 29, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEA |
|
| June 16, 2020 |
EXHIBIT 21 SUBSIDIARIES JRSIS Health Care Limited, organized in the British Virgin Islands Runteng Medical Group Company Limited, organized in Hong Kong Harbin Jiarun Hospital Co. |
|
| June 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-56013 JRSIS HEALTH CA |
|
| May 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2020 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| May 14, 2020 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: February 28, 2022 Washington, D. |
|
| March 24, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2020 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| February 26, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2020 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Empl |
|
| February 13, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2020 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Empl |
|
| February 13, 2020 |
JRSIS Health Care Corporation (OTCQX: JRSS) Send Medical Specialists to Hubei Amid Epidemic Exhibit 99.1 JRSIS Health Care Corporation (OTCQX: JRSS) Send Medical Specialists to Hubei Amid Epidemic HEILONGJIANG PROVINCE, P.R. CHINA, Feb. 13, 2020 - JRSIS Health Care Corporation. ("JRSS" or "the Company") (OTCQX: JRSS), a Florida corporation that owns and operates a network of three hospitals in Harbin City, China, today announced that in February 12 JRSS sent a first group of 10 medical s |
|
| November 13, 2019 |
Harbor Gates Convertible Promissory Note Agreement EX-10.1 2 f10q0919ex10-1jrsishealth.htm HARBOR GATES CONVERTIBLE PROMISSORY NOTE AGREEMENT Exhibit 10.1 Note: July 15, 2019 NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES |
|
| November 13, 2019 |
Auctus Convertible Promissory Note Agreement EX-10.2 3 f10q0919ex10-2jrsishealth.htm AUCTUS CONVERTIBLE PROMISSORY NOTE AGREEMENT Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANS |
|
| November 13, 2019 |
JRSS / JRSIS Health Care Corp 10-Q - Quarterly Report - QUARTERLY REPORT 10-Q 1 f10q0919jrsishealthcare.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition pe |
|
| November 13, 2019 |
Auctus Common Stock Purchase Warrant Agreement Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| September 30, 2019 |
Submission of Matters to a Vote of Security Holders 8-K 1 f8k092619jrsishealth.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2019 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State |
|
| September 26, 2019 |
JRSS / JRSIS Health Care Corp POS AM - - POST-EFFECTIVE AMENDMENT TO FORM S-1 As filed with the Securities and Exchange Commission on September 26, 2019 Registration No. |
|
| September 26, 2019 |
Exhibit 5.3 ROBERT BRANTL, ESQ. 52 Mulligan Lane Irvington, NY 10533 914-693-3026 September 26, 2019 JRSIS Health Care Corporation No. 38 South Street, Hulan Town Hulan District, Harbin City Heilongjiang Province, P.R. China 150025 Re: Post-Effective Amendment No. 1 to Registration Statement on Form S-1, File No. 333-224703 (the “Registration Statement”) Ladies and Gentlemen: I have acted as couns |
|
| September 20, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEAL |
|
| August 15, 2019 |
JRSS / JRSIS Health Care Corp DEFA14A - - DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| August 15, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| August 14, 2019 |
JRSS / JRSIS Health Care Corp NT 10-Q - - NOTIFICATION OF LATE FILING UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Washington, D. |
|
| June 14, 2019 |
Convertible Promissory Note issued to Labrys Fund, LP; Issue Date: May 30, 2019 Exhibit 10(b) NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| June 14, 2019 |
Exhibit 10(a) SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 30, 2019, by and between JRSIS Health Care Corporation, a Florida corporation, with headquarters located at 1st – 7th Floor, Industrial and Commercial Bank Bldg. |
|
| June 14, 2019 |
JRSIS Health Care Corporation Completes Convertible Financing EX-99 4 f8k061219ex99jrsishealth.htm PRESS RELEASE DATED JUNE 14, 2019 Exhibit 99 JRSIS Health Care Corporation Completes Convertible Financing Press Release | 06/14/2019 HARBIN CITY, P.R. CHINA, June 14, 2019 — JRSIS Health Care Corporation (OTCQX: JRSS), a Florida corporation that owns and operates a network of three hospitals in Harbin City, China, today announced completion of a financing with |
|
| June 14, 2019 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2019 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| May 15, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56013 JRSIS HEA |
|
| April 26, 2019 |
JRSIS HEALTH CARE CORPORATION Declares Dividend on Common Stock EX-99 2 s117692ex99.htm EXHIBIT 99 Exhibit 99.1 Press Release: JRSIS HEATH CARE CORPORATION Declares Dividend on Common Stock JRSIS HEALTH CARE CORPORATION Declares Dividend on Common Stock NEW YORK, UNITED STATES, April 26, 2019 - JRSIS Health Care Corporation (OTCQX: JRSS), a corporation organized in the United States under the laws of the State of Florida, which owns one main hospital and two b |
|
| April 26, 2019 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2019 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| April 1, 2019 |
EX-21 2 s117031ex21.htm EXHIBIT 21 EXHIBIT 21 SUBSIDIARIES JRSIS Health Care Limited, organized in the British Virgin Islands Runteng Medical Group Company Limited, organized in Hong Kong Harbin Jiarun Hospital Co., Ltd., organized in the People’s Republic of China Harbin Jiarun Hospital Co., Ltd. (Nanjing Road), organized in the People’s Republic of China Harbin Jiarun Hospital Co., Ltd. (Second |
|
| April 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 (Mark One) FORM10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Commission file number: 001-36758 JRSIS HEALTH CAR |
|
| December 18, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Its Charter) Florida 46-4562047 (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No. |
|
| November 13, 2018 |
JRSS / JRSIS Health Care Corp FORM 10-Q (Quarterly Report) 10-Q 1 tv50683510q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commis |
|
| November 6, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2018 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Emplo |
|
| September 6, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2018 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida 1-36758 46-4562047 (State or Other Jurisdiction (Commission (I.R.S. Empl |
|
| September 6, 2018 |
EX-3.A 2 tv502423ex3a.htm EXHIBIT 3-A Exhibit 3-a AMENDED AND RESTATED BYLAWS OF JRSIS HEALTH CARE CORPORATION September 3, 2018 ARTICLE I OFFICES AND CORPORATE SEAL SECTION 1.1 Registered Office. The registered office of JRSIS HEALTH CARE CORPORATION , (hereinafter the "Corporation") in the State of Florida shall be c/o South Milhausen, P.A., 1000 Legion Center, Suite 1200, Orlando, FL 32801. In |
|
| August 13, 2018 |
JRSS / JRSIS Health Care Corp FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36758 JRSIS HEAL |
|
| July 30, 2018 |
JRSS / JRSIS Health Care Corp POS AM As filed with the Securities and Exchange Commission on July 30, 2018 Registration No. |
|
| June 19, 2018 |
JRSS / JRSIS Health Care Corp CORRESP June 19, 2018 Via Edgar Re: JRSIS Health Care Corp. Registration Statement on Form S-1 Filed May 21, 2018 File No. 333-224703 After careful consideration and To Whom It May Concern: Pursuant to Rule 461 of Regulation C (“Rule 461”) promulgated under the Securities Act of 1933, as amended, JRSIS Health Care Corp (the “Company”) hereby requests that the effectiveness of the above-referenced Registra |
|
| June 15, 2018 |
JRSS / JRSIS Health Care Corp CORRESP June 15, 2018 Via Edgar Re: JRSIS Health Care Corp. Registration Statement on Form S-1 Filed May 21, 2018 File No. 333-194359 After careful consideration and To Whom It May Concern: Pursuant to Rule 461 of Regulation C (“Rule 461”) promulgated under the Securities Act of 1933, as amended, JRSIS Health Care Corp (the “Company”) hereby requests that the effectiveness of the above-referenced Registra |
|
| June 15, 2018 |
JRSS / JRSIS Health Care Corp CORRESP June 15, 2018 Via Edgar Re: JRSIS Health Care Corp. Post Effective Amendment Number 4 to Registration Statement on Form S-1 Filed May 16, 2018 File No. 333-194359 After careful consideration and To Whom It May Concern: Pursuant to Rule 461 of Regulation C (“Rule 461”) promulgated under the Securities Act of 1933, as amended, JRSIS Health Care Corp (the “Company”) hereby requests that the effective |
|
| May 21, 2018 |
JRSS / JRSIS Health Care Corp S-1/A As filed with the Securities and Exchange Commission on May 21, 2018 Registration No. |
|
| May 16, 2018 |
JRSS / JRSIS Health Care Corp POS AM As filed with the Securities and Exchange Commission on May 16, 2018 Registration No. |
|
| May 14, 2018 |
JRSS / JRSIS Health Care Corp FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36758 JRSIS HEA |
|
| May 7, 2018 |
JRSS / JRSIS Health Care Corp FORM S-1 As filed with the Securities and Exchange Commission on May 7, 2018 Registration No. |
|
| May 7, 2018 |
JRSS / JRSIS Health Care Corp POS AM As filed with the Securities and Exchange Commission on May 7, 2018 Registration No. |
|
| April 17, 2018 |
JRSS / JRSIS Health Care Corp FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 (Mark One) FORM10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Commission file number: 001-36758 JRSIS HEALTH CAR |
|
| April 13, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 29, 2017 JRSIS Health Care Corporation (Exact name of registrant as specified in its charter) Florida 001-36758 46-4562047 (State or other jurisdiction of incorporation) (Commi |
|
| April 2, 2018 |
JRSS / JRSIS Health Care Corp NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10K ¨ Form 20F ¨ Form 11K ¨ Form 10Q ¨ Form 10D ¨ Form NSAR ¨ Form NCSR For Period Ended: December 31, 2017 ¨ Transition Report on Form 10K ¨ Transition Report on Form 20F ¨ Transition Report on Form 11K ¨ Transition Report on Form 10Q ¨ Transition Report on Form NSAR |
|
| November 13, 2017 |
JRSS / JRSIS Health Care Corp FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36758 JRSIS |
|
| August 14, 2017 |
JRSS / JRSIS Health Care Corp 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36758 JRSIS HEAL |
|
| June 30, 2017 |
As filed with the Securities and Exchange Commission on June 30, 2017 Registration No. |
|
| May 15, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36758 JRSIS HEA |
|
| March 29, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 (Mark One) FORM10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-194359 JRSIS HEALTH C |
|
| November 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194359 JRS |
|
| October 19, 2016 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2016 JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Charter) Florida 333-194359 46-4562047 (State or Other Jurisdiction (Commission File Number) ( |
|
| October 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2016 JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Charter) Florida 333-194359 46-4562047 (State or Other Jurisdiction (Commission File Number) (I |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194359 JRSIS HEA |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194359 JRSIS HEA |
|
| June 24, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2016 JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Charter) Florida 333-194359 46-4562047 (State or Other Jurisdiction (Commission File Number) (IRS |
|
| May 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194359 JRSIS HE |
|
| May 6, 2016 |
Letter of AWC (CPA) Limited dated May 5, 2016 EX-16.1 2 v439132ex16-1.htm EXHIBIT 16.1 EXHIBIT 16.1 Letter of AWC (CPA) Limited dated May 5, 2016 AWC (CPA) Limited CERTIFIED PUBLIC ACCOUNTANTS 7/F, Nan Dao Commercial Building 359-361 Queen’s Road Central Hong Kong Tel : (852) 2851 7954 Fax: (852) 2545 4086 May 5, 2016 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 We have read the statements made by JRSIS Health |
|
| May 6, 2016 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2016 (May 5, 2016) JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Charter) Florida 333-194359 46-4562047 (State or Other Jurisdiction (Commission File |
|
| April 1, 2016 |
As filed with the Securities and Exchange Commission on April 1, 2016 Registration No. |
|
| March 29, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 (Mark One) FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-194359 JRSIS HEALTH |
|
| November 16, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 v42425410q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commiss |
|
| October 26, 2015 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2015 JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Charter) Florida 333-194359 46-4562047 (State or Other Jurisdiction (Commission File Number) ( |
|
| October 26, 2015 |
EXHIBIT 99.1 Press Release JHCC Receives US Trading Symbol JRSS from FINRA and Commences Trading in the USA Harbin, Heilongjiang Province ? (October 26, 2015) ? JRSIS Health Care Corp. (?JHCC? or the ?Company?) is pleased to announce that on October 23, 2015, the Financial Industry Regulatory Authority (?FINRA?) cleared the hares of our Company?s common stock to commence trading on the Over the Co |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194359 JRSIS HEA |
|
| May 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194359 JRSIS HE |
|
| March 31, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-K R ANNUAL REPORT PURSUANT TO SECTION13OR15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-194359 JRSIS HEALTH CA |
|
| March 16, 2015 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2015 JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Charter) Florida 333-194359 46-4562047 (State or Other Jurisdiction (Commission File Number) (IR |
|
| March 16, 2015 |
EX-99.1 2 v404597ex99-1.htm EXHIBIT 99.1 EXHIBIT 99.1 Press Release JRSIS HEALTH CARE CORPORATION CLOSES ITS REGISTERED OFFERING OF 6,411,000 SHARES OF ITS COMMON STOCK March 16, 2015 – JRSIS HEALTH CARE CORPORATION. (“JHCC” or the “Company”), a full service medical facility, JHCC is serving patients on a municipal and county level and providing both Western and Chinese medical practices to the ci |
|
| March 9, 2015 |
Exhibit 1.01 March 4, 2015 Summarized Terms of Engagement Our letter of agreement (?Agreement?) confirms our understanding that the JRSIS HEALTH CARE CORPORATION (the ?Client?) has engaged Halcyon Cabot Partners, Ltd. (?Halcyon?) to act as the Client?s advisor in connection with the provision of services for the Client (the ?Assignment? or ?Assignment(s)?), on the terms and conditions set forth be |
|
| March 9, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2015 JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Charter) Florida 333-194359 46-4562047 (State or Other Jurisdiction (Commission File Number) (IRS |
|
| January 9, 2015 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 v3984578k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2015 JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Charter) Florida 333-194359 46-4562047 (State or Other Jurisdictio |
|
| January 9, 2015 |
EX-99.1 2 v398457ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JRSIS HEALTH CARE CORPORATION Appoints ALBERT WONG & CO. as its New Independent Registered Public Accounting Firm January 08, 2015 – JRSIS HEALTH CARE CORPORATION. (“JHCC” or the “Company”), a full service medical facility, JHCC is serving patients on a municipal and county level and providing both Western and Chinese medical practices to the c |
|
| December 22, 2014 |
Letter from DeJoya Griffith to the U.S. Securities and Exchange Commission EXHIBIT 16.1 Letter from DeJoya Griffith to the U.S. Securities and Exchange Commission December 22, 2014 Securities and Exchange Commission 100 F Street NE Washington, DC 20549 RE: Jrsis Health Care Corporation We have read the statements that we understand Jrsis Health Care Corporation will include under Item 4.01 of the Form 8-K report it will file regarding the recent change of auditors. We ag |
|
| December 22, 2014 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 v3973688k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2014 JRSIS HEALTH CARE CORPORATION (Exact Name of Registrant as Specified in Charter) Florida 333-194359 46-4562047 (State or Other Jurisdict |
|
| December 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-194359 JRSI |
|
| November 20, 2014 |
JRSS / JRSIS Health Care Corp 8-A12B - - FORM 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 JRSIS HEALTH CARE CORPORATION (Exact name of registrant as specified in its charter) Florida (State of incorporation or organization) 46-4562047 (I.R.S. Employer Identification No.) 1 st – 7 th Flo |
|
| November 10, 2014 |
JRSS / JRSIS Health Care Corp CORRESP - - CORRESP 1 filename1.htm Via EDGAR U.S. Securities and Exchange Commission 100 F Street, NE Washington DC 20549 Attention: Ms. Christina DeRosa November 10, 2014 Re: JRSIS Health Care Corporation Registration Statement on Form S-1 (Amendment No. 7) File No. 333-194359 Filed: March 6, 2014 Dear Ms. DeRosa: Further to your telephone call to Mr. William O’Neal, JRSIS Health Care Corporation. hereby re |
|
| November 10, 2014 |
JRSS / JRSIS Health Care Corp CORRESP - - CORRESP 1 filename1.htm Via EDGAR U.S. Securities and Exchange Commission 100 F Street, NE Washington DC 20549 Attention: Ms. Christina DeRosa Re: JRSIS Health Care Corporation Registration Statement on Form S-1 (Amendment No. 7) File No. 333-194359 Filed: March 6, 2014 Dear Ms. DeRosa: Further to your telephone call to Mr. William O’Neal, JRSIS Health Care Corporation. hereby requests acceleratio |
|
| October 30, 2014 |
The shareholder investment confirmation letter (1) EX-10.8 2 v392645ex10-8.htm EXHIBIT 10.8 Exhibit 10.8 |
|
| October 30, 2014 |
JRSS / JRSIS Health Care Corp S-1/A - - FORM S-1/A S-1/A 1 v392645s1a.htm FORM S-1/A As filed with the Securities and Exchange Commission on October 30, 2014 Registration No. 333-194359 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A Amendment No. 7 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JRSIS HEALTH CARE CORPORATION. (Exact name of Registrant as specified in its charter) Florida 8099 46-4562047 (State or othe |
|
| October 15, 2014 |
JRSS / JRSIS Health Care Corp CORRESP - - October 15, 2014 VIA ELECTRONIC MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| October 15, 2014 |
Exhibit 10.7 |
|
| October 15, 2014 |
JRSS / JRSIS Health Care Corp S-1/A - - S-1/A As filed with the Securities and Exchange Commission on October 15, 2014 Registration No. |
|
| September 23, 2014 |
JRSS / JRSIS Health Care Corp S-1/A - - FORM S-1/A As filed with the Securities and Exchange Commission on September 23, 2014 Registration No. |
|
| September 23, 2014 |
Supplementary Description Terms for the Articles of Harbin Jiarun Hospital Co., Ltd (1) Exhibit 10.6 |
|
| August 29, 2014 |
JRSS / JRSIS Health Care Corp CORRESP - - JRSIS HEALTH CARE CORPORATION August 29, 2014 VIA ELECTRONIC MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| August 5, 2014 |
Agreement on Modification to Contract and Articles of Association (1) Exhibit 10.5 |
|
| August 5, 2014 |
BVI-Registration Form on January 14, 2014(1) Exhibit 3.5 |
|
| August 5, 2014 |
BVI-Registration Form on November 08, 2013(1) Exhibit 3.3 |
|
| August 5, 2014 |
Capital Verification Report (1) Exhibit 99.2 |
|
| August 5, 2014 |
Certificate of Incumbency on January 22, 2014 (1) Exhibit 3.6 |
|
| August 5, 2014 |
Certificate of Incumbency on November 22, 2013(1) Exhibit 3.4 |
|
| August 5, 2014 |
JRSS / JRSIS Health Care Corp CORRESP - - JRSIS HEALTHCARE CORPORATION August 5, 2014 VIA ELECTRONIC MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| August 5, 2014 |
20131009-COI-China Runteng Medical Group Co., Ltd (1) Exhibit 3.7 |
|
| August 5, 2014 |
Exhibit 10.4 |
|
| August 5, 2014 |
JRSS / JRSIS Health Care Corp S-1/A - - S-1/A As filed with the Securities and Exchange Commission on August 05, 2014 Registration No. |
|
| July 9, 2014 |
JRSS / JRSIS Health Care Corp CORRESP - - JRSIS HEALTHCARE CORPORATION July 9, 2014 VIA ELECTRONIC MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| July 9, 2014 |
JRSS / JRSIS Health Care Corp S-1/A - - AMENDMENT TO FORM S-1 S-1/A 1 v383477s1a.htm AMENDMENT TO FORM S-1 As filed with the Securities and Exchange Commission on July 09, 2014 Registration No. 333-194359 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JRSIS HEALTH CARE CORPORATION. (Exact name of Registrant as specified in its charter) Florida 8099 46-4562047 (State o |
|
| June 6, 2014 |
S-1/A 1 v380793s1a.htm S-1/A As filed with the Securities and Exchange Commission on June 6, 2014 Registration No. 333-194359 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 Amendment No. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JRSIS HEALTH CARE CORPORATION. (Exact name of Registrant as specified in its charter) Florida 8099 46-4562047 (State or other jurisdict |
|
| June 6, 2014 |
June 6, 2014 VIA ELECTRONIC MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| June 6, 2014 |
Exhibit 10.3 1 2 3 4 5 6 |
|
| May 1, 2014 |
May 1, 2014 VIA ELECTRONIC MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| May 1, 2014 |
As filed with the Securities and Exchange Commission on May 1, 2014 Registration No. |
|
| March 6, 2014 |
Articles of Incorporation of Registrant (1) EXHIBIT 3.1 ARTICLES OF INCORPORATION OF JRSIS HEALTH CARE CORPORATION The undersigned Incorporator hereby subscribes to and adopts these Articles of Incorporation for the purpose of organizing a business corporation for profit under the Florida Business Corporation Act, Florida Statutes Chapter 607. ARTICLE I CORPORATE NAME The name of this Corporation shall be: JRSIS HEALTHCARE CORPORATION ARTIC |
|
| March 6, 2014 |
Form of Subscription Agreement (1) EXHIBIT 99.1 JRSIS HEALTH CARE CORPORATION Subscription Agreement 1. Investment: The undersigned (“Buyer”) subscribes for Shares of Common Stock of JRSIS HEALTH CARE CORPORATION $0.5725 per share. Total subscription price ($0.5725) times number of Shares): = $. PLEASE MAKE CHECKS PAYABLE TO: JRSIS HEALTH CARE CORPORATION 2. Investor information: Name (type or print) SSN/EIN/Taxpayer I.D. E-Mail ad |
|
| March 6, 2014 |
Financial Leasing Contract (1) Exhibit 10.2 Contract Number: *[2013]N.Z.Z.D.No.1301 Financial Leasing Contract Leaser: Harbin Baiyi Real Estate Development Co., Ltd Leasee: Harbin Jiarun Hospital Co., Ltd Leaser: Harbin Baiyi Real Estate Development Co., Ltd. Add: Rm.21 of First Floor (of Hulan Tower), Group 2 and Community 2, Construction Street, Hulan District, Harbin. Legal Representative: Zhang Junsheng Tel: 0451-56888933 F |
|
| March 6, 2014 |
EXHIBIT 3.2 BYLAWS OF JRSIS HEALTH CARE CORPORATION December 20, 2013 ARTICLE I OFFICES AND CORPORATE SEAL SECTION 1.1 Registered Office. The registered office of JRSIS HEALTH CARE CORPORATION , (hereinafter the "Corporation") in the State of Florida shall be c/o South Milhausen, P.A., 1000 Legion Center, Suite 1200, Orlando, FL 32801. In addition to its registered office, the Corporation shall ma |
|
| March 6, 2014 |
As filed with the Securities and Exchange Commission on March 6, 2014 Registration No. |
|
| March 6, 2014 |
Exhibit 10.1 House Leasing Contract Leaser (Party A): Zhang Junsheng Leasee (Party B): Harbin Jiarun Hospital Co., Ltd This Agreement is formulated and concluded by and between the Leaser and the Leasee through equity and voluntary in accordance with the Contract Law of the People's Republic of China and provisions of rules and regulations. Article I. In so far as the leasing house is located at1s |
